CRL logo

CRL Shareholders equity

annual shareholders equity:

$3.46B-$135.38M(-3.76%)
December 28, 2024

Summary

  • As of today (May 31, 2025), CRL annual stockholders equity is $3.46 billion, with the most recent change of -$135.38 million (-3.76%) on December 28, 2024.
  • During the last 3 years, CRL annual shareholders equity has risen by +$926.68 million (+36.56%).
  • CRL annual shareholders equity is now -3.76% below its all-time high of $3.60 billion, reached on December 30, 2023.

Performance

CRL Shareholders equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCRLbalance sheet metrics

quarterly shareholders equity:

$3.19B-$267.17M(-7.72%)
March 29, 2025

Summary

  • As of today (May 31, 2025), CRL quarterly stockholders equity is $3.19 billion, with the most recent change of -$267.17 million (-7.72%) on March 29, 2025.
  • Over the past year, CRL quarterly shareholders equity has dropped by -$446.10 million (-12.25%).
  • CRL quarterly shareholders equity is now -15.54% below its all-time high of $3.78 billion, reached on September 28, 2024.

Performance

CRL quarterly shareholders equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCRLbalance sheet metrics

Shareholders equity Formula

Shareholders Equity = Total Assets − Total Liabilities

CRL Shareholders equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-3.8%-12.3%
3 y3 years+36.6%+22.4%
5 y5 years+111.8%+93.4%

CRL Shareholders equity Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-3.8%+36.6%-15.5%+22.4%
5 y5-year-3.8%+111.8%-15.5%+93.4%
alltimeall time-3.8%+3242.8%-15.5%+2973.3%

CRL Shareholders equity History

DateAnnualQuarterly
Mar 2025
-
$3.19B(-7.7%)
Dec 2024
$3.46B(-3.8%)
$3.46B(-8.5%)
Sep 2024
-
$3.78B(+1.6%)
Jun 2024
-
$3.72B(+2.3%)
Mar 2024
-
$3.64B(+1.2%)
Dec 2023
$3.60B(+20.9%)
$3.60B(+8.8%)
Sep 2023
-
$3.31B(+1.7%)
Jun 2023
-
$3.25B(+4.6%)
Mar 2023
-
$3.11B(+4.4%)
Dec 2022
$2.98B(+17.4%)
$2.98B(+13.3%)
Sep 2022
-
$2.63B(-0.8%)
Jun 2022
-
$2.65B(+1.4%)
Mar 2022
-
$2.61B(+3.0%)
Dec 2021
$2.53B(+19.9%)
$2.53B(+4.5%)
Sep 2021
-
$2.43B(+4.7%)
Jun 2021
-
$2.32B(+6.2%)
Mar 2021
-
$2.18B(+3.3%)
Dec 2020
$2.11B(+29.4%)
$2.11B(+11.5%)
Sep 2020
-
$1.90B(+8.2%)
Jun 2020
-
$1.75B(+6.1%)
Mar 2020
-
$1.65B(+1.1%)
Dec 2019
$1.63B(+24.1%)
$1.63B(+6.7%)
Sep 2019
-
$1.53B(+5.3%)
Jun 2019
-
$1.46B(+4.1%)
Mar 2019
-
$1.40B(+6.1%)
Dec 2018
$1.32B(+26.1%)
$1.32B(+5.1%)
Sep 2018
-
$1.25B(+6.0%)
Jun 2018
-
$1.18B(+3.7%)
Mar 2018
-
$1.14B(+9.1%)
Dec 2017
$1.05B(+24.9%)
$1.05B(+2.3%)
Sep 2017
-
$1.02B(+6.0%)
Jun 2017
-
$963.50M(+9.9%)
Mar 2017
-
$876.43M(+4.7%)
Dec 2016
$836.77M(+14.1%)
$836.77M(-3.6%)
Sep 2016
-
$867.97M(+4.4%)
Jun 2016
-
$831.35M(+6.6%)
Mar 2016
-
$779.82M(+6.4%)
Dec 2015
$733.07M(+9.1%)
$733.07M(+4.1%)
Sep 2015
-
$704.36M(+0.4%)
Jun 2015
-
$701.70M(+5.7%)
Mar 2015
-
$663.71M(-1.3%)
Dec 2014
$672.20M(+4.9%)
$672.20M(+0.3%)
Sep 2014
-
$670.30M(-0.2%)
Jun 2014
-
$671.82M(-3.4%)
Mar 2014
-
$695.46M(+8.5%)
Dec 2013
$640.98M(+6.7%)
$640.98M(-2.4%)
Sep 2013
-
$656.51M(+1.3%)
Jun 2013
-
$647.95M(+3.1%)
Mar 2013
-
$628.28M(+4.6%)
Dec 2012
$600.80M
$600.80M(+0.5%)
Sep 2012
-
$597.71M(+6.2%)
DateAnnualQuarterly
Jun 2012
-
$562.84M(+1.9%)
Mar 2012
-
$552.60M(+5.1%)
Dec 2011
$525.58M(-23.5%)
$525.58M(-2.6%)
Sep 2011
-
$539.71M(-8.4%)
Jun 2011
-
$589.09M(+4.6%)
Mar 2011
-
$562.92M(-18.1%)
Dec 2010
$687.42M(-50.0%)
$687.42M(-34.0%)
Sep 2010
-
$1.04B(-25.5%)
Jun 2010
-
$1.40B(+0.8%)
Mar 2010
-
$1.39B(+0.8%)
Dec 2009
$1.38B(+14.7%)
$1.38B(+1.9%)
Sep 2009
-
$1.35B(+5.2%)
Jun 2009
-
$1.28B(+5.4%)
Mar 2009
-
$1.22B(+1.6%)
Dec 2008
$1.20B(-35.6%)
$1.20B(-38.4%)
Sep 2008
-
$1.95B(+0.1%)
Jun 2008
-
$1.95B(+1.9%)
Mar 2008
-
$1.91B(+2.7%)
Dec 2007
$1.86B(+16.6%)
$1.86B(+3.2%)
Sep 2007
-
$1.80B(+4.2%)
Jun 2007
-
$1.73B(+5.3%)
Mar 2007
-
$1.64B(+2.9%)
Dec 2006
$1.60B(-12.7%)
$1.60B(+2.7%)
Sep 2006
-
$1.55B(-5.3%)
Jun 2006
-
$1.64B(-5.5%)
Mar 2006
-
$1.74B(-4.9%)
Dec 2005
$1.83B(+24.1%)
$1.83B(+2.3%)
Sep 2005
-
$1.79B(+3.1%)
Jun 2005
-
$1.73B(+14.1%)
Mar 2005
-
$1.52B(+3.1%)
Dec 2004
$1.47B(+216.9%)
$1.47B(+167.3%)
Sep 2004
-
$550.82M(+6.1%)
Jun 2004
-
$519.06M(+5.1%)
Mar 2004
-
$494.00M(+6.3%)
Dec 2003
$464.62M(+30.0%)
$464.62M(+7.6%)
Sep 2003
-
$431.94M(+4.9%)
Jun 2003
-
$411.70M(+8.2%)
Mar 2003
-
$380.35M(+6.4%)
Dec 2002
$357.38M(+23.4%)
$357.38M(+7.4%)
Sep 2002
-
$332.84M(+7.5%)
Jun 2002
-
$309.54M(+7.3%)
Mar 2002
-
$288.41M(-0.4%)
Dec 2001
$289.51M(+141.5%)
$289.51M(+4.3%)
Sep 2001
-
$277.67M(+33.4%)
Jun 2001
-
$208.22M(+4.6%)
Mar 2001
-
$199.14M(+66.1%)
Dec 2000
$119.86M(-208.8%)
$119.86M(+6.0%)
Sep 2000
-
$113.09M(-204.1%)
Jun 2000
-
-$108.66M(-2.3%)
Mar 2000
-
-$111.17M
Dec 1999
-$110.14M(-165.5%)
-
Dec 1998
$168.26M
-

FAQ

  • What is Charles River Laboratories International annual stockholders equity?
  • What is the all time high annual shareholders equity for Charles River Laboratories International?
  • What is Charles River Laboratories International annual shareholders equity year-on-year change?
  • What is Charles River Laboratories International quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for Charles River Laboratories International?
  • What is Charles River Laboratories International quarterly shareholders equity year-on-year change?

What is Charles River Laboratories International annual stockholders equity?

The current annual shareholders equity of CRL is $3.46B

What is the all time high annual shareholders equity for Charles River Laboratories International?

Charles River Laboratories International all-time high annual stockholders equity is $3.60B

What is Charles River Laboratories International annual shareholders equity year-on-year change?

Over the past year, CRL annual stockholders equity has changed by -$135.38M (-3.76%)

What is Charles River Laboratories International quarterly stockholders equity?

The current quarterly shareholders equity of CRL is $3.19B

What is the all time high quarterly shareholders equity for Charles River Laboratories International?

Charles River Laboratories International all-time high quarterly stockholders equity is $3.78B

What is Charles River Laboratories International quarterly shareholders equity year-on-year change?

Over the past year, CRL quarterly stockholders equity has changed by -$446.10M (-12.25%)
On this page